ImmunityBio (IBRX) Return on Invested Capital Growth (5y) (2020 - 2022)

ImmunityBio (IBRX) Return on Invested Capital Growth (5y) (2020 - 2022) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 ImmunityBio 7.22 Bn 6.84 Bn 43.97 Mn

Historic Data

Download Data
DateValue
Jun 30, 2022 -3.00
Mar 31, 2022 9.00
Dec 31, 2021 8.00
Sep 30, 2021 16.00
Jun 30, 2021 25.00
Mar 31, 2021 75.00
Dec 31, 2020 162.00
Sep 30, 2020 545.00